A longitudinal study of rheumatoid arthritis in South Africans

MedGenMed Medscape General Medicine

Volumn 5, Issue 1, 2003, Pages

  Tikly, Mohammed ^a   Zannettou, Nedi ^a   Hopley, Mark ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

AUR, auranofin; CQ, chloroquine sulphate; D PEN, d penicillamine; IM gold, sodium aurothiomalate; MTX, methotrexate; SSZ, sulphasalazine

Indexed keywords

AURANOFIN; AUROTHIOMALATE; C REACTIVE PROTEIN; CHLOROQUINE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; FUNGAL MENINGITIS; HOSPITAL CARE; HUMAN; HUMAN CELL; INFECTION; LIFE TABLE; LOBAR PNEUMONIA; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT REFERRAL; PHYSICAL DISABILITY; PRESCRIPTION; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SOUTH AFRICA; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL TIME;

EID: 25144505742     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am. 1993;19:123-151.
2. Furst DE. Predictors of worsening clinical variables and outcomes in rheumatoid arthritis. Rheum Clin North Am. 1994;20:309-319.
3. Soderlin MK, Nieminen P, Hakala M. Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol. 1998;25:1895-1899.
4. Scott DL, Symmons DPM, Coulton BL, Popert AJ. Long-term outcome of treating rheumatoid arthritis. Lancet. 1987;1:1108-1111.
5. Pincus T, Ferraccioli G, Sokka T, et al. Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology. 2002;41:1346-1356.
6. Scott DL, Strand V. The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database. Rheumatology. 2002;41:899-909.
7. Abdel-Nasser AM, Rasker JJ, Valkenburg HA. Epidemiological and clinical aspects relating in the variability of rheumatoid arthritis. Semin Arthritis Rheum. 1997;27:123-140.
8. Solomon L, Robin G, Valkenburg HA. Rheumatoid arthritis in an urban South African Negro population. Ann Rheum Dis. 1975;34:128-135.
9. Adebajo AO, Reid DM. The pattern of rheumatoid arthritis in West Africa and comparison with a cohort of British patients. Q J Med. 1991;80:633-640.
10. Chikanaza IC, Stein M, Lutalo S, Gibson T. The clinical, serologic and radiologic features of rheumatoid arthritis in ethnic black Zimbabwean and British Caucasian patients. J Rheumatol. 1994;21:2011-2015.
11. Mody GM, Meyers OL. Rheumatoid arthritis in blacks in South Africa. Ann Rheum Dis. 1989;48:69-72.
12. Arnett FA, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1987;31:315-324.
13. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1991;35:498-502.
14. StatSoft. STATISTICA for Windows v 5.1 1998. Tulsa, Oklahoma. http://www.statsoft.com.
15. Dawson B, Trapp RG. Basic & Clinical Biostatistics. 3rd ed. New York: Langer Medical Books/McGraw-Hill; 2001.
16. van der Heijde DM, van Riel PL, Nuyer-Zwart IH, Gribnal GW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet .1989;1:1036-1038.
17. Moolenburgh JD, Moore S, Valkenberg HA. Rheumatoid arthritis in Lesotho. Ann Rheum Dis. 1984;43:40-43.
18. Pike KD, Tikly M, Bell JI, Wordsworth BP. HLA-DR antigens and rheumatoid arthritis in black South Africans. Tissue Antigens. 1992;39:138-140.
19. Dossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JMW. Long-term course and outcome of functional capacity in rheumatoid arthritis. Arthritis Rheum. 1999;42:1854-1860.
20. Bergstrom U, Book C, Lindroth Y, Marsal L, Saxne T, Jacobsson L. Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978. Scand J Rheumatol. 1999;28:160-165.
21. McEntergart A, Morrison E, Capell HA, et al. The effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis. 1997;56:410-413.
22. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum. 2002;46:328-346.
23. Wolfe F, Hawley DJ, Cathey MA. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1014 consecutive starts. J Rheumatol. 1990;17:994-1002.
24. Pincus T, Marcum SB, Callahan LF. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J Rheumatol. 1992;19:1885-1894.
25. Olsen NJ, Callahan LF, Pincus T. Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 1987;30:481-488.
26. Daniels ED, Pettifor JM, Schnitzler CM, Russell SW, Patel DN. Ethnic differences in bone density in female South Africans. J Bone Miner Res. 1995;10:359-367.
27. Massardo L, Gabriel SE, Crowson CS, O'Fallon WM, Matteson E. A population based assessment of the use of orthopedic surgery in patients with rheumatoid arthritis. J Rheumatol. 2002;29:52-56.